Web2 jan. 2024 · Fig. 1 Main injection sites for antipsychotic long-acting injections: (a) dorsogluteal site; (b) ventrogluteal site; (c) deltoid site; (d) vastus lateralis site. (a) … WebLong-acting injectables/depot delivery systems are formulations intended for prolonged/sustained drug release over a long period of time ranging from a few days to months. Depot delivery systems enhance product quality by decreasing dosing frequency, simplifying the drug regimen.
Psychoses and related disorders Treatment summaries BNF NICE
Web8. Wartelsteiner F, Hofer A. Treating schizophrenia with 2 long-acting injectable antipsychotic drugs: a case report. J Clin Psychopharmacol. 2015;35(4):474-475. 9. Scangos KW, Caton M, Newman WJ. Multiple long-acting injectable antipsychotics for treatment-resistant schizophrenia: case report. J Clin Psychopharmacol. 2016;36(3):283 … Web7 rijen · 5 mrt. 2024 · Long-Acting Injectable (LAI) Antipsychotics are antipsychotics delivered via intramuscular injection that can provide medication coverage from a period of weeks to months. Once stabilized on an LAI, patients rarely will need oral … billy watson knives
Antipsychotic long-acting injections in clinical practice: …
Web7 dec. 2024 · iStock/Alernon77. The “long” in long-acting injectable (LAI) antipsychotics extended its reach this past fall, as the U.S. Food and Drug Administration (FDA) approved the first twice-yearly injectable of paliperidone palmitate (marketed as Invega Hafyera by Janssen). Prior to this approval, the longest coverage offered by an LAI was three ... Web7 feb. 2024 · Long-acting injectable antipsychotics have been shown to prevent symptom relapse while addressing patient adherence. However, questions remain regarding their … Web22 sep. 2024 · Despite the efficacy and safety of second-generation antipsychotic (SGA) long-acting injectables (LAIs) in treating schizophrenia, psychiatrists have not considered these agents as first-line ... billy watson tv